CrushSCI.com
202.7平均天数
205中位天数
61最短天数
393最长天数
4542025发文量

Paper Review Records

全部论文审稿周期

21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

391 天

Precision oncology in advanced melanoma: molecular landscapes and personalized therapy recommendations from the Molecular Tumor Board Freiburg

作者
T. Lowinus; V. Schipperges; P. Metzger; T. Brummer; U. Matysiak; E. P. Dopfer; M. E. Hess; M. Fahrner; T. Pauli; A. Blaumeiser; H. Becker; J. Kuehn; M. Rassner; J. Falkenstein; H. Bertemes; P. Bovio; N. Pinter; S. Cysar; S. Lehr; R. Wäsch; L. Gräßel; K. Eyerich; A. M. Schultheis; O. Schilling; S. Lassmann; M. Werner; A. L. Illert; J. Duyster; R. Zeiser; C. C. Miething; M. Boerries; F. Meiss; D. Rafei展开收起
作者单位
1. Department of Medicine I—Medical Centre—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 2. Comprehensive Cancer Center Freiburg, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3. Institute of Medical Bioinformatics and Systems Medicine (IBSM), Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 4. German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between DKFZ and Medical Center—University of Freiburg, Freiburg, Germany; 5. Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany; 6. Institute for Surgical Pathology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 7. Department of Dermatology and Venereology—Medical Centre—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 8. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany; 9. Department of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich (TUM), Munich, Germany; 10. Center of Personalized Medicine, Technical University of Munich (TUM), University Hospital, Technical University of Munich, Munich, Germany展开收起
PDF源文件 DOI 网页
342 天

Machine learning uncovers previously undetectable genetic deletions in cancer panel sequencing

作者
Irina A. Kerle; Oleksandr Husak; Thomas Gross; Andreas Hartig; Rebecca Prause; Daniela Richter; Sascha Brückmann; Maximilian Werner; Anja Kögler; Dorothea Hanf; Lino Möhrmann; Doreen William; Karsten Wendt; Nicole Pfarr; Carolin Mogler; Daniela E. Aust; Evelin Schröck; Christoph Heining; Hanno Glimm展开收起
作者单位
1. Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; 2. Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 3. German Cancer Consortium (DKTK), partner site Dresden, a partnership between DKFZ and University Hospital Carl Gustav Carus Dresden, Dresden, Germany; 4. Chair of Software Technology, Faculty of Computer Science, Technical University Dresden, Dresden, Germany; 5. Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 6. Institute of Pathology, Carl Gustav Carus University Hospital, Dresden, Germany; 7. Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 8. Computational Health Informatics Program, Boston Children’s Hospital, Harvard Medical School, Boston, USA; 9. Internal Medicine C, Hematology, Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Greifswald, Germany; 10. Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany; 11. ERN GEN-TURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; 12. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; German Cancer Consortium (DKTK), partner site: Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 13. Institute of Pathology, School of Medicine and Health, Technical University Munich, Munich, Germany展开收起
PDF源文件 DOI 网页
100 天

Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia

作者
Xuekang Qi; Georgios Mermelekas; Ondrej Hodek; Luay Aswad; Quentin Glaziou; Isabelle Rose Leo; Nona Struyf; Femke M. Hormann; Ioannis Siavelis; Henri Colyn Bwanika; Owen F. J. Hovey; Martin Haraldsson; Sean G. Rudd; Annika I. Johansson; Tom Erkers; Katja Pokrovskaja Tamm; Janne Lehtiö; Rozbeh Jafari展开收起
作者单位
1. Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden; 2. Swedish Metabolomics Centre, Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Umeå, Sweden; 3. Molecular Precision Medicine, Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden; 4. Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden; 5. Department of Oncology-Pathology, Karolinska Institutet, J6:140 BioClinicum, Solna, Sweden; 6. Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 7. Swedish Metabolomics Centre, Department of Plant Physiology, Umeå University, Umeå, Sweden展开收起
PDF源文件 DOI 网页
107 天

Skill-guided agentic reasoning enables longitudinal synthesis of myeloma records at expert-level concordance

作者
Johannes Moll; Jannik Lübberstedt; Christoph Nuernbergk; Jacob Stroh; Luisa Mertens; Anna Purcarea; Christopher Zirn; Zeineb Benchaaben; Fabian Drexel; Hartmut Häntze; Anirudh Narayanan; Friedrich Puttkammer; Andrei Zhukov; Jacqueline Lammert; Sebastian Ziegelmayer; Markus Graf; Marion Högner; Marcus Makowski; Florian Bassermann; Lisa C. Adams; Jiazhen Pan; Daniel Rueckert; Krischan Braitsch; Keno K. Bressem展开收起
作者单位
1. Chair for AI in Healthcare and Medicine, Technical University of Munich (TUM) and TUM University Hospital, Munich, Germany; 2. Technical University of Munich, School of Medicine and Health, TUM University Hospital, Klinikum rechts der Isar, Department of Diagnostic and Interventional Radiology, Munich, Germany; 3. Technical University of Munich, School of Medicine and Health, TUM University Hospital, German Heart Center, Department of Cardiovascular Radiology and Nuclear Medicine, Munich, Germany; 4. Technical University of Munich, School of Medicine and Health, TUM University Hospital, Klinikum rechts der Isar, Department of Medicine III, Munich, Germany; 5. Department of Radiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; 6. Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; 7. Chair of Medical Informatics, Institute of Artificial Intelligence in Medicine and Healthcare, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany; 8. Clinical Department of Gynecology, TUM University Hospital, TUM School of Medicine and Health, Munich, Germany; 9. TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany; 10. Deutsches Konsortium für Translationale Krebsforschung, Heidelberg, Germany; 11. Bavarian Cancer Research Center, Munich, Germany; 12. Department of Engineering Science, University of Oxford, Oxford, UK; 13. Munich Center for Machine Learning (MCML), Munich, Germany; 14. Department of Computing, Imperial College London, London, UK; 15. National Center for Tumor Diseases West, Essen, Germany; 16. Institute of Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany; 17. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany展开收起
PDF源文件 DOI 网页
216 天

Minigene-based characterization and classification of splice-associated variants in succinate dehydrogenase B

作者
Anni Köhler; Alexandra A. Baumann; Natasha Lewis; Anja Richter; Susan Richter; Doreen William; Andrés Cruz-García; Hanno Glimm; Stefan Fröhling; Diana Le Duc; Evelin Schröck; Arne Jahn展开收起
作者单位
1. Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany; 2. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 3. ERN-GENTURIS, Hereditary Cancer Syndrome Center, Dresden, Germany; 4. DKTK, Partner Site Dresden, Dresden, Germany; 5. Department of Systems Biology and Bioinformatics, University of Rostock, Rostock, Germany; 6. Institute for Medical Informatics and Biometry, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 7. Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand; 8. Core Unit for Molecular Tumor Diagnostics (CMTD), NCT/UCC Dresden, a Partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 9. Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 10. Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 11. Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 12. National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; 13. German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; 14. Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany展开收起
PDF源文件 DOI 网页
248 天

A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions

作者
Julius Thyen; Victor A. Sioson; Daniel Haak; Beatrix Jahnke; Maximilian Fusenig; Abdul M. Aftab; Antonia Stammberger; Sascha Brückmann; Heike Polster; Stefanie Hübner; Verena J. Kast; Manuel Pfeifer; Rebecca Prause; Vivian Mittné; Carolin Beer; Malin H. Reinhart; Adrian M. Seifert; Lena Seifert; Martin Bornhäuser; Carsten Werner; Marc Schmitz; Daniela E. Aust; Jürgen Weitz; Daniela Loessner; Daniel E. Stange; Anna R. Poetsch; Mathieu Pecqueux; Franziska Baenke展开收起
作者单位
1. Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 2. Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials, Dresden, Germany; 3. Biomedical Genomics, Biotechnology Center, Center for Molecular and Cellular Bioengineering, TUD Dresden University of Technology, Dresden, Germany; 4. Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 5. Institute of Pathology and Tumor- and Normal Tissue Bank of the University Cancer Center (UCC), University Hospital Carl Gustav Carus, Medical Faculty, TUD Dresden University of Technology, Dresden, Germany; 6. Institute of Legal Medicine, Medizinische Fakultät, TUD Dresden University of Technology, Dresden, Germany; 7. Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases Dresden (NCT/UCC), Dresden, Germany; 8. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; 9. German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. Else Kröner Clinician Scientist Professor for Translational Tumor Immunological Research, TUD Dresden University of Technology, Dresden, Germany; 11. Medical Clinic I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; 12. Center for Regenerative Therapies Dresden (CRTD) and Cluster of Excellence Physics of Life (PoL), TUD Dresden University of Technology, Dresden, Germany; 13. Department of Chemical and Biological Engineering and Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Melbourne, Australia; 14. Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; 15. Institute for Genetics, University of Cologne, Cologne, Germany; 16. Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; 17. Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。